A Safety/Tolerance Phase, Ascending Single Dose Study to Evaluate the Safety and Tolerability of G3P-01, a Food-Grade Pectic Product, in Healthy Volunteers (G3P-01-01)
Sponsor: EB Medical Research
This NA trial investigates Gastrointestinal Discomfort and Performance Status and is currently completed. EB Medical Research leads this study, which shows 6 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jul 2022 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jun 2022 — Jul 2022 [monthly]
Recruiting NA
▶ Show 1 earlier version
-
Apr 2022 — Jun 2022 [monthly]
Recruiting NA
First recorded
Mar 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- EB Medical Research
- Quartesian
- SQ Innovation, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .